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Abstract
Background: Metallothionein-I and -II (MT-I/II) is produced by reactive astrocytes in the injured brain and has been
shown to have neuroprotective effects. The neuroprotective effects of MT-I/II can be replicated in vitro which
suggests that MT-I/II may act directly on injured neurons. However, MT-I/II is also known to modulate the immune
system and inflammatory processes mediated by the immune system can exacerbate brain injury. The present
study tests the hypothesis that MT-I/II may have an indirect neuroprotective action via modulation of the immune
system.
Methods: Wild type and MT-I/II
-/- mice were administered cryolesion brain injury and the progression of brain
injury was compared by immunohistochemistry and quantitative reverse-transcriptase PCR. The levels of circulating
leukocytes in the two strains were compared by flow cytometry and plasma cytokines were assayed by
immunoassay.
Results: Comparison of MT-I/II
-/- mice with wild type controls following cryolesion brain injury revealed that the
MT-I/II
-/- mice only showed increased rates of neuron death after 7 days post-injury (DPI). This coincided with
increases in numbers of T cells in the injury site, increased IL-2 levels in plasma and increased circulating leukocyte
numbers in MT-I/II
-/- mice which were only significant at 7 DPI relative to wild type mice. Examination of mRNA for
the marker of alternatively activated macrophages, Ym1, revealed a decreased expression level in circulating
monocytes and brain of MT-I/II
-/- mice that was independent of brain injury.
Conclusions: These results contribute to the evidence that MT-I/II
-/- mice have altered immune system function
and provide a new hypothesis that this alteration is partly responsible for the differences observed in MT-I/II
-/- mice
after brain injury relative to wild type mice.
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Background
Metallothionein (MT) is a 6-7 kDa, cysteine-rich, zinc-
binding protein that has antioxidant properties. MT-I
and MT-II are similar isoforms, often considered to
behave as one species (MT-I/II), that share the ability to
provide protection to the injured brain. During insult to
the central nervous system (CNS), metallothionein-I and
-II double knockout (MT-I/II
-/-)m i c es h o wi n c r e a s e d
neuron death or larger injury size after brain injury
[1-3]. This firmly suggests that the presence of MT-I/II
provides protection against CNS perturbation but the
precise mechanisms that underlie this are yet to be
identified. In vitro experiments have demonstrated that
MT-I/II can provide protection, directly to neurons,
against zinc toxicity [4] and can protect astrocytes from
oxidative stress [5]. In a regenerative context, MT-I/II
can enhance neurite extension in neurons [6]. However,
a defining characteristic of brain injury in MT-I/II
-/-
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such as microglia or macrophages, and T cells compared
to wild type mice [2,7,8]. Notably, MT-I/II has been
shown to affect immune system processes such as
immunoglobulin production [9-14]. Leukocytes infiltrate
the injured CNS and have the potential to be neurotoxic
which makes it difficult to determine if the increased
cell death observed in the injured brains of MT-I/II
-/-
mice is due to the absence of the neuroprotective effects
of MT-I/II in the CNS or the absence of the modulatory
effects that MT-I/II has on the immune system.
The infiltration of neutrophils into CNS injuries is the
most rapid of any type of leukocyte but neutrophils do
not persist beyond 2 days post-injury, at which time
monocytes become the dominant infiltrating leukocyte
[15]. T cell infiltration occurs in several waves with an
early infiltration within 1 hour [16], followed by a sec-
ond infiltration at 24 hours [17]. However, the maximal
T cell occupation of the injured CNS begins to occur
about 1 week after the initial injury [18]. Evidence sug-
gests that many immune system processes, such as
inflammatory cytokine production and the oxidative
burst, are neurotoxic and can impede the resolution of
brain injury [19-21]. It is feasible that the number of
immune cells entering the CNS can influence the pro-
gression of brain injury but the phenotype of the
immune cells may also affect this process. For example,
naïve helper T cells can take on one of several pheno-
types when they first become activated; the predominant
types are type 1 helper T cell phenotype and the type 2
helper T cell phenotype [22]. Th1 cells promote the for-
mation of classically activated macrophages (caMFs)
and augment the production of pro-inflammatory cyto-
kines and reactive oxygen species and other neurotoxic
molecules whereas Th2 cells promote formation of
alternatively activated macrophages (aaMFs) which
antagonise these processes [23]. In vitro caMFsh a v e
been shown to cause neuron death meanwhile aaMFs
appear to be less neurotoxic and possibly have some
neurotrophic properties [24]. There is some evidence
that T cells from MT-I/II
-/- mice are more responsive to
stimuli that induce Th1 cells [25] and differences in the
numbers of circulating leukocytes in MT-I/II
-/- mice
relative to wild type mice have been observed [9].
Therefore, it is possible that the altered inflammatory
response in the injured brain of MT-I/II
-/- mice is a
result of an altered immune system but this has not
been investigated in depth.
In the present study we used a cryolesion injury model
to compare the number of T cells infiltrating the injury
site in wild type and MT-I/II
-/- mice. Analysis of the
numbers of leukocytes in circulation in the days follow-
ing brain injury was also conducted to determine if the
altered immune response to injury in MT-I/II
-/- mice
occurs before the cells enter the injured brain. Levels of
the mRNA marker of aaMFs, Ym1, were assayed to
determine if MT-I/II
-/- mice have different ratios of
caMFs/aaMFs in comparison to wild type mice after
brain injury.
Methods
Animals
All procedures involving animals were approved by the
Animal Experimentation Ethics Committee of the Uni-
versity of Tasmania and were consistent with the Aus-
t r a l i a nC o d eo fP r a c t i c ef o rt h eC a r ea n dU s eo f
Animals for Scientific Purposes. Breeding stock for
129SI/SvImJ (wild type) mice and 129S7/SvEvBrd-
Mt1
tm1Bri Mt2
tm1Bri/J (MT-I/II
-/-)m i c e[ 2 6 ]w e r e
obtained from Jackson Laboratories. Male mice from
both strains were housed with food and water ad libi-
tum with 12/12 hour light/dark cycling. Mice used in
the experiment were between 12 and 36 weeks of age.
For each experiment, mice from both strains were
divided evenly into groups of 5-7 animals for sampling
time (0, 1, 3 and 7 days post-injury, DPI) and animals
within these groups were randomised and placed in
numbered cages to blind the strain of the mouse from
the researchers. Each mouse was housed in an individual
cage for at least 3 days prior to injury surgery and dur-
ing the period after surgery until euthanasia.
Cryolesion brain injury
The cryolesion injury method was adapted from [27].
Mice were anaesthetised with 2-3% isoflurane/oxygen
mix, delivered to the animal at 0.6 L/min. A 3 mm dia-
meter, 50 mm long steel rod was cooled in liquid nitro-
gen. A sagittal incision along the skull was used to
expose the cranium and the steel rod was then applied
directly to the skull for 6 seconds. The stereotaxic coor-
dinates for the injury site were 4 mm anterior of lambda
and 2 mm right of the midline. The skin was sutured
and the animal was allowed to recover back in its origi-
nal cage. Mortality rate was less than 1% with a few ani-
mals showing signs of seizure within the first 24 hours
after the application of the cryolesion injury. These ani-
mals were euthanized and excluded from the study.
Immunohistochemistry
Mice were transcardially perfused with phosphate buf-
fered saline (PBS); brains were dissected out of the skull
and drop-fixed in 4% paraformaldehyde for 24 hours.
The brains were embedded in wax and sectioned at 10
μm thickness. Before staining, antigen retrieval was
undertaken in 0.01 M citrate buffer, pH 6, in a pressure
cooker for 10 minutes. Primary antibodies used were
1:100 rat monoclonal NIMP-R14 to neutrophil (Abcam,
Cambridge, UK) for neutrophils, 1:500 goat polyclonal
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macrophages and 1:100 rabbit polyclonal anti-CD3
(Abcam) was used for T cells. All antibodies were
diluted with 0.3% Triton-X 100 (Sigma, St. Lous, MO,
USA) solution in PBS. Blocking with serum-free protein
block (Dako, Glostrup, Denmark) was required for CD3
staining and was applied for 30 minutes before applica-
tion of the primary antibody. The diluted NIMP-R14
antibody solution contained 10% normal goat serum
(Vector Labs, Burlingame, CA, USA) as a blocking
reagent. Biotinylated goat anti-rat IgG (Invitrogen,
Carlsbad, CA, USA), biotinylated goat anti-rabbit IgG
(Invitrogen) or donkey anti-goat IgG (Santa Cruz, Santa
Cruz, CA USA) secondary antibodies, were applied to
sections at 1:1000 dilution for 1 hour at room tempera-
ture. Avidin-biotin complex (Vector Labs) was used as
the detection reagent and was applied to sections for 15
minutes followed by 2 rinses in PBS. Nickel enhanced
3’3-diaminobenzidine (DAB, Vector Labs) was used as
the chromogen and was applied at the manufacturer’s
specified concentration for 8 minutes. Slides were then
rinsed in distilled water for at least 5 minutes. Nuclear
F a s tR e d( S i g m a )w a su s e da sac o u n t e r s t a i nf o rN I M P -
R14 and Iba1 stained sections.
Fluoro-jade C staining
Fluoro-jade C (Millipore, Billerica, MA, USA) is a neuron-
specific marker of dead and degenerating neurons. Stain-
ing was carried out according to the protocol of Schmued
et al. [28] whom demonstrated that fluoro-jade C labels
both apoptotic and necrotic neuron death without discri-
mination. Rehydrated, slide-mounted sections were
immersed in 0.06% potassium permanganate solution for
10 minutes. The slides were rinsed for 2 minutes in dis-
tilled water then immersed in 0.0001% fluoro-jade C,
0.01% acetic acid solution for 10 minutes. The slides were
rinsed twice in distilled water for 5 minutes then were air-
dried before they were coverslipped with DPX mounting
medium (Merck, Whitehouse Station, NJ, USA).
In situ cell counts in the injured brain
Low power, 10 × objective images were taken of the
injury site for sections stained for fluoro-jade C, NIMP-
R14, Iba1 and CD3. Fluoro-jade C counts were con-
ducted for all positively labelled cells in the injury site
and at lower depths in the un-injured CNS parenchyma.
To standardise cell counts, fluoro-jade C counts were
divided by the linear width of the injury in the section
plane at the upper cortical surface in millimeters.
N I M P - R 1 4 ,I b a 1a n dC D 3p o s i t i v ec e l l sw e r eo n l y
counted within the injury site. Cell counts within the
injury site were standardised to the area of the injury
site in that section in mm
2. The injury border was
demarcated by an obvious degradation of tissue integrity
observed in the injury site. The border of this region
correlated well with the GFAP
+ endfeet extended by
astrocytes as they re-established the glia limitans at days
3 and 7 DPI (data not shown). The glia limitans was not
re-established at this injury border at 1 DPI but the
pyknotic nuclei stained by nuclear fast red that likely
represent apoptotic cells were rarely found outside this
zone of reduced tissue integrity. Therefore this boundary
was deemed to be a physiologically relevant demarcation
o ft h ei n j u r yz o n e .A l lc e l lc o u n t sw e r ec o n d u c t e d
blinded to the strain of the mouse.
Flow cytometry
Blood was obtained by cardiac puncture and the leuko-
cytes were separated from erythrocytes by Histopaque
1119 (Sigma) density gradient centrifugation. For CD3
and CD4 double labelling, 10
6 leukocytes were used for
each batch of staining. Leukocytes were stained with a
combination of 1 μg/ml APC-conjugated hamster IgG1
anti-mouse CD3e (BD Biosciences, Franklin Lakes, NJ,
USA) and 1 μg/ml PE-conjugated rat IgG2a anti-mouse
CD4 (BD biosciences) in 200 μlP B S - 2 % F C Sa t4 ° Cf o r
15 minutes. The cells were pelleted by centrifugation,
and washed twice by resuspension in PBS-2%FCS fol-
lowed by centrifugation to pellet. The pellet was resus-
pended in a fixation solution consisting of 2%
paraformaldehyde, 4% D-glucose, 0.03% sodium azide
and 0.01 M PBS for storage. For CD4
+CD25
+FoxP3
+
naturally occurring regulatory T cells, 10
6 cells were
used for each batch of staining and were labelled with
the mouse regulatory T cell staining kit # 2 (eBioscience,
San Diego, CA, USA) according to the manufacturer’s
protocol. Staining procedures were also carried out for
isotype control antibodies, PE-conjugated rat IgG2a (BD
Biosciences) and APC-conjugated hamster IgG1 (BD
Biosciences), which were applied at the same concentra-
tion as the specific antibodies to unstained cells. Sam-
ples were assayed by flow cytometry (BD Canto II flow
cytometer) and were analysed using BD FACS Diva soft-
ware v6.1.1. A quadratic gate was applied to the scatter
p l o t so fC D 3v e r s u sC D 4f l u o r e s c e n c et oi d e n t i f yC D 3
+CD4
+ and CD3
+CD4
- T cells which were expressed as
a percentage of all leukocytes. To identify naturally
occurring regulatory T cell populations, a gate was
applied to cells expressing CD4. Cells within the CD4
+
population gate were analysed with a quadratic gate
applied to the scatter plots of CD25 versus FoxP3. CD4
+CD25
+FoxP3
+ cells are expressed as a percentage of
CD4
+ cells. The distinction between positive and nega-
tive staining was determined by the upper fluorescence
of isotype control stained cells. All thresholds and gates
were applied on this basis. To determine absolute circu-
lating leukocyte numbers, blood was obtained from
mice by cardiac puncture with syringes containing
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whole blood was analysed in an Advia 120 haemocytolo-
gical analyser (Siemens, Munich, Germany).
Quantitative reverse-transcriptase PCR (RT-PCR)
Mice were transcardially perfused with PBS. The brain
injury site was dissected out of the brain using a 3 mm
biopsy punch and homogenised via Ultra-Turrax (IKA,
Staufen, Germany) in TRI-reagent (Sigma, St. Louis, MO,
USA). Peripheral blood mononuclear cells (PBMCs) were
obtained using density gradient centrifugation on Histopa-
que 1083 (Sigma) and the pelleted cells from this fraction
were homogenised in TRI-reagent. RNA was isolated from
TRI-reagent according to the manufacturer’sp r o t o c o l .
Reverse transcription with the Superscript-III reverse tran-
scriptase system (Invitrogen) and quantitative PCR with
Quantitect SYBR green (Qiagen, Hilden, Germany) was
conducted according to the method of Brettingham-
Moore et al. [29]. Oligonucleotide primers are detailed in
table 1. The MT-I and MT-II primer sets were designed
to be complementary to the cDNA for the transcripts
from both wild type and MT-I/II
-/- mice, which still pro-
duce MT-I and MT-II transcripts but have premature
stop codons inserted to prevent complete protein transla-
tion. Standard curves were created using known quantities
of each PCR product and were used to determine the ori-
ginal cDNA copy number at an arbitrary fluorescence
threshold (CT). GAPDH mRNA was used as the house
keeping gene and MT-I and MT-II mRNA copy numbers
were standardized to the copy number of the house-keep-
ing gene, GAPDH.
Plasma cytokine assay
Blood was collected from mice via cardiac puncture with
heparinised syringes. Plasma was obtained after
centrifugation of blood for 5 minutes at 14000g. Plasma
samples were diluted four-fold with PBS and assayed
with a cytometric bead array mouse Th1/Th2/Th17
cytokine kit (BD biosciences). The assay was run accord-
ing to specification and analysis was conducted using
FCAP Array software v1.0.1. IL-4 and IFN-g were
assayed with ELISA kits (R&D systems, Minneapolis,
MN, USA) according to manufacturer’s protocol.
Statistical Analysis
Statistical analysis was conducted with SPSS 15.0 (SPSS
Inc.). Homogeneity of variances between groups within
each data set was determined with Levene’st e s t .B o x -
Cox test was used to determine the appropriate trans-
formation for data sets with heterogeneous variances
between groups. Statistical significance was determined
with two-way ANOVA for p-values < 0.05 with Tukey’s
B Post-hoc test. All error bars in figures represent the
standard error of the mean (SEM).
Results
Histological comparison of the extent of injury in wild
type and MT-I/II
-/- mice
The area of the injury site in a 5 μm section taken from
the widest point of the injury site was used as a compara-
tive measure of injury size. The size of the injury did not
change significantly from 1-3 DPI but declined signifi-
cantly from 3-7 DPI in both wild type mice and MT-I/II
-/-
mice (Figure 1A). No significant differences were observed
between the strains at any time-point which suggests that
on a large scale, the severity of the injury and rate of heal-
ing is similar in wild type and MT-I/II
-/- mice. However,
investigation of the death of individual neurons revealed
some notable differences between the two strains of
mouse. Fluoro-jade C is a histological dye that labels neu-
rons dying by both apoptosis and necrosis [28] and was
found to label neurons in the lesion site and in the sur-
rounding, uninjured parenchyma (Figure 1B). Quantifica-
tion of fluoro-jade C labelled cells revealed that the
highest degree of cell death occurred at 1 day post-injury
(DPI, Figure 1B). In wild type mice the number of fluoro-
jade C labelled cells decreased from 1-3 DPI and again at
3-7 DPI. MT-I/II
-/- mice had a similar decrease in fluoro-
jade C staining from 1-3 DPI compared to wild type mice.
In contrast to wild-type mice, the amount of cell death did
not differ between 3 and 7 DPI in the injury site of MT-I/
II
-/- mice. As a result, there were significantly greater num-
bers of fluoro-jade C labelled cells in MT-I/II
-/- mice at 7
DPI than in wild type mice.
Leukocyte infiltration into the injury site in wild type and
MT-I/II
-/- mice
Leukocyte infiltration into the cryolesion at 1, 3 and 7
DPI was investigated to determine if leukocytes could
Table 1 Oligonucleotide primer sets used for quantitative
RT-PCR of brain mRNA samples after cryolesion brain
injury.
Primer Sequence (5’ -3 ’) Accession No.
GAPDH Fwd CCCAGAAGACTGTGGATGG NM_008084.2
Rev GGATGCAGGGATGATGTTCT
IFN-g Fwd ACTGGCAAAAGGATGGTGAC NM_008337.3
Rev GACCTGTGGGTTGTTGACCT
IL-4 Fwd TCAACCCCCAGCTAGTTGTC NM_021283.2
Rev TCTGTGGTGTTCTTCGTTGC
Ym1 Fwd ACAATTTAGGAGGTGCCGTG NM_009892.2
Rev CCAGCTGGTACAGCAGACAA
MT-I Fwd GCTGTCCTCTAAGCGTCACC NM_013602.3
Rev AGGAGCAGCAGCTCTTCTTG
MT-II Fwd CAAACCGATCTCTCGTCGAT NM_008630.2
Rev AGGAGCAGCAGCTTTTCTTG
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MT-I/II
-/- mice. Neutrophils were identified by immu-
nohistochemistry for NIMP-14 and were at their highest
levels in the injury site at 1 DPI coinciding with the
highest amount of neuron death (Figure 2A).
Neutrophil numbers were greatly diminished at 3 DPI
and mostly absent from the injury site at 7 DPI. No sig-
nificant differences were found between neutrophil
numbers in the injury site of wild-type and MT-I/II
-/-
mice at 1, 3 or 7 DPI. Neutrophils were found mainly
within the injury site but were occasionally found in the
uninjured parenchyma proximal to the injury border.
Iba1 staining was used to identify macrophages
derived from activated microglia and infiltrating mono-
cytes within the injury site (Figure 2B). Macrophages
within the injury site increased from 1-3 DPI and
reached maximal numbers for the study period at 7
DPI. No significant differences in macrophage numbers
between MT-I/II
-/- and wild type mice were observed at
any time point.
CD3 antibody was used to identify T cells in the
injury site (Figure 2C). T cells were found to be mainly
confined to the injury site. T cell numbers were found
to be relatively low at 1 and 3 DPI with no significant
differences between injuries of wild type and MT-I/II
-/-
mice. However, at 7 DPI, T cell numbers were greatly
increased compared to the earlier time points. MT-I/II
-/-
mice had significantly more T cells per mm
2 in the
injury site than wild type mice at 7 DPI.
Metallothionein expression in the cryolesion injury site
The levels of MT-I and MT-II mRNA were assessed
post-injury in wild type mice by quantitative RT-PCR.
MT-I (Figure 3A) and MT-II (Figure 3B) mRNA both
show significant increases in expression relative to
GAPDH at 1 DPI. MT-II appears to be the dominant
isoform of MT with 41.1 fold higher levels of expression
than MT-I relative to GAPDH. At 3 and 7 DPI, MT-II
mRNA was decreased but remained significantly ele-
vated relative to the uninjured cortex, whereas MT-I
mRNA had returned to pre-injury levels. It is interesting
to note that peak MT-I and MT-II mRNA expression in
the brain does not coincide with observed differences in
neuron death and T cell infiltration in wild type and
MT-I/II
-/- mice.
Circulating leukocyte numbers in wild type and MT-I/II
-/-
mice after brain injury
Previous studies have found MT-I/II
-/- mice to have
altered levels of circulating leukocytes and leukocyte sub-
types [9]. A haematological analyser was used to deter-
mine whether differences in absolute numbers of white
blood cells in MT-I/II
-/- mice and wild type mice might
account for differences in leukocyte infiltration rates into
the cryolesion-affected tissue (Figure 4A). Leukocyte
counts from whole peripheral blood did not significantly
change after brain injury in wild type mice at 0 (unin-
j u r e d ) ,1 ,3o r7D P I .M T - I / I I
-/- mice had no significant
changes in leukocyte numbers in whole peripheral blood
from 0-3 DPI but had significantly higher leukocyte
counts at 7 DPI compared to uninjured controls and wild
type mice at 7 DPI (Figure 4A). Analysis of circulating
neutrophils, lymphocytes and monocytes revealed no dif-
ferences in the relative ratios of any leukocyte sub-type
(Figure 4B). Basophils and eosinophils constituted a
small fraction of all leukocytes and numbers did not
increase after injury in MT-I/II
-/- mice and do not
explain the increased levels of leukocytes in MT-I/II
-/-
mice at 7 DPI (data not shown). Because the haematolo-
gical analyser did not differentiate between sub-classes of
lymphocytes, flow cytometry was used to determine if
relative ratios of T cells were equal in MT-I/II
-/- mice
and wild type mice (Figure 5A). By 7 DPI, there was a sig-
nificant overall decrease in CD3
+CD4
+ helper T cells in
both MT-I/II
-/- mice and wild type mice. However, there
was no significant difference at any timepoint between
these two groups of mice. There was also no difference in
numbers of CD3
+CD4
- T cells, the majority of which are
likely to consist of cytotoxic T cells (data not shown).
Figure 1 Quantification of injury size and neuron death after
cryolesion injury in wild type (grey bars) and MT-I/II
-/- mice
(white bars). Injury size (A) was quantified by measurement of the
area of the injury in sections taken from the widest point of the
injury site. Neuron death identified by fluoro-jade C labelling (B).
Fluorojade-C+ cells were counted in the injury site and the
surrounding tissue. Counts were standardised per linear mm (width)
of the injury site. Lower case letters indicate significance determined
by Tukey’s B post-hoc test. Time-points sharing letters indicates lack
of statistically significant difference. n = 5-7, error bars = SEM.
Representative images of fluoro-jade C staining in the injury site of
wild type animals at 1 DPI (C), 3 DPI (D) and 7 DPI (E) with scale
bars = 200 μm.
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+CD25
+FoxP3
+ naturally occurring regulatory T
cells have been shown to reduce the impact of stroke
[30] and may have similar protective roles in the injured
brain. However, the number of CD4
+CD25
+FoxP3
+
naturally occurring regulatory T cells as a percentage of
CD4
+ T cells was not found to vary significantly at 3 or
7 DPI between wild type and MT-I/II
-/- mice (Figure
5C). Therefore, there were no differences in the ratios
of any of the leukocyte sub-types investigated in wild
type and MT-I/II
-/- mice after brain injury. However,
the increase in absolute leukocyte numbers observed in
MT-I/II
-/- mice at 7 DPI allows us to calculate that
there would be an average increase of 16% in the abso-
lute number of circulating T cells in MT-I/II
-/- mice at
7 DPI. Because there was no increase in the absolute
number of leukocytes in wild type mice, the same calcu-
lation determines that absolute numbers of circulating T
cells would have decreased by 26% on average by 7 DPI.
This result is in accordance with the finding that T cell
numbers are lower in the brain of wild type mice com-
pared to MT-I/II
-/- mice at 7 DPI.
Comparison of chemokine and cytokine expression in
wild type and MT-I/II mice
Plasma concentrations of Th1 and Th2 cytokines were
assayed to determine if there were systemic differences
in the inflammatory response to brain injury. Unfortu-
nately most of the cytokines tested were not detectable
or were only rarely detected (IL-4, IL-6, INF-g,T N F - a
and IL-10) which suggests that the cryolesion does not
induce a strong systemic inflammatory response. How-
ever, it is known that T cells must be activated before
they can enter the CNS [31,27] and the cytokine, IL-2
which is responsible for T cell activation, was detectable
Figure 2 Leukocyte counts in sections of the injury site of MT-I/II
-/- mice (white bars) and wild type mice (grey bars) standardised to
injury area. Neutrophil numbers (A) were determined by NIMP-14 immunoreactivity. Microglial and monocyte derived macrophages numbers
(B) were determined by Iba1 immunoreactivity. T cell numbers (C) were determined by CD3 immunoreactivity. Lower case letters indicate
significance determined by Tukey’s B post-hoc test. Time-points sharing letters indicates lack of statistically significant difference. n = 5-7, error
bars = SEM. Immunohistochemistry within the injury site is shown for neutrophils at 1 DPI with nuclear-fast red counter stain (D), macrophages
at 7 DPI with nuclear-fast red counter stain (E) and T cells at 7 DPI without counterstain (D). Arrows indicate examples of positively stained cells,
Scale bars = 100 μm.
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1 and 3 DPI, IL-2 was detected in some animals from
both the wild type and MT-I/II
-/- groups. At 7 DPI, only
MT-I/II
-/- mice had detectable plasma concentrations of
IL-2 with 4 out of 6 animals exhibiting detectable
expression of IL-2. No wild type animals had detectable
levels of IL-2 at 7 DPI. Statistical analysis could not be
conducted on this data set due to the high number of
animals with plasma IL-2 concentrations lower than the
detection limit.
IL-4 and IFN-g mRNA could not be detected in the
injury site of either strain of mouse, yet both transcripts
were detectable in RNA harvested from a mouse T cell
line that had been stimulated with calcium ionophore
and phorbol ester to induce a state of activation (data
not shown). IL-4 and IFN-g protein could not be
detected in the injury site of MT-I/II
-/- mice and wild
type mice. Overall, systemic cytokine activation was not
observed after brain injury and local T cell specific cyto-
kines were undetectable so Th1 and Th2 responses
could not be compared directly in wild type and MT-I/
II
-/- mouse injury sites.
To assess the effect of increased numbers of T cells in
the injury site, quantitative RT-PCR was used to assess
the levels of mRNA for the alternative macrophage acti-
vation marker, Ym1, in the cryolesion site (Figure 7A).
Ym1 expression increased significantly at 1 DPI in the
injury site of wild type and MT-I/II
-/- mice as deter-
mined by 2-way ANOVA. It was also determined that
wild type mice have significantly higher levels of Ym1
compared to MT-I/II
-/- mice independent of the factor
of time before or after injury.
Using this method, it was impossible to determine
whether the Ym1 is derived from the CNS-resident
microglia or infiltrating monocytes because both cell
types contribute to the pool of activated macrophages in
t h ei n j u r ys i t e .T oe x a m i n ew h e t h e rt h ei n c r e a s e dY m 1
in wild type mice occurs in monocytes before they enter
the injured brain, RT-PCR was used to determine Ym1
levels in PBMCs (Figure 7B). Monocytes are the only
cell type in this cell fraction that express Ym1. 2-way
ANOVA revealed that there were no significant changes
in Ym1 expression over time, but wild type animals
express significantly higher levels of Ym1 mRNA in
their PBMCs compared to MT-I/II
-/- mice.
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Figure 3 MT-I and MT-II mRNA expression in wild type mice
after cryolesion brain injury was measured by quantitative RT-
PCR. Peak expression for both mRNAs was observed at 1 DPI with
statistical significance relative to uninjured animals. For all groups n
= 7 except for wild type mice at zero DPI where n = 6, error bars =
SEM. Figure 4 Circulating leukocyte counts after brain injury were
obtained with the Advia 120 haemocytological analyser.
Absolute cell numbers (A) show an increase at 7 DPI which was
significantly different to all time points for wild type mice and from
0-3 DPI time points for MT-I/II
-/- mice as determined by Tukey’sB
post-hoc test. n = 4-6, error bars = SEM. Relative ratios of leukocytes
(B) were compared between wild type mice (solid lines) and MT-I/
II
-/- mice (dashed lines) for lymphocytes (blue circles), neutrophils
(purple crosses) and monocytes (red triangles). No significant
differences were found between strains for any cell type and no
significant changes over time were found for any cell type. n = 4-6,
error bars = SEM.
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The present study demonstrates that the altered
immune response present in MT-I/II
-/- mice occurs in
later stages of brain injury. The significant findings of
increased T cell infiltrate into the injury site, increased
levels of IL-2, prolonged neuronal death surrounding
the injury site and increased numbers of circulating leu-
kocytes were all only present in MT-I/II
-/- mice at 7
DPI. However, the finding that MT-I/II
-/- mice have
altered expression of Ym1 mRNA in the brain and cir-
culating monocytes, both before and after injury, sug-
gests that at least some aspects of the altered immune
response in MT-I/II
-/- mice are independent of brain
injury. The implication of these findings is that MT-I/II
may be having effects on the immune system systemi-
cally hence MT-I/II may be affecting the progression of
brain injury indirectly via modulation of inflammatory
responses.
A latent period before increased neuron death in MT-
I/II
-/- mice compared to wild type mice has been
reported previously [1] which is in accordance with the
findings of the present study. However, increased neu-
r o nd e a t hi nM T - I / I I
-/- mice has also been observed
within 24 hours of brain injury by Penkowa et al. [2].
One of the criticisms of the study by Penkowa et al. [2]
is that neuron death in the cryolesioned cortex was
assessed by counting the number of remaining neuron-
specific enolase labelled neurons immediately adjacent
Figure 5 CD4
+ T cell ratios after brain injury were assessed by flow cytometry for CD3 and CD4 labelled cells shown in a
representative scatter plot (B). Temporal changes in CD4
+ T cell ratios after brain injury reveal no significant differences between wild type
(solid line) and MT-I/II
-/- mice (dashed line) (A), n = 6-7, error bars = SEM. The CD4
+ cell gate revealed the ratios of CD25
+ and FoxP3
+ naturally
occurring regulatory T cells (C). At 3 and 7 DPI no significant differences were observed between wild type mice (grey bars) and MT-I/II
-/- mice
(white bars) (D), n = 7, error bars = SEM.
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injury site was larger in MT-I/II
-/- mice compared to
the wild type controls, hence neuron counts from MT-
I/II
-/- mice would have come from deeper cortical layers
than in wild type mice. It is well known that there are
large differences in the density and distribution of neu-
rons in different layers of the cortex [32]. Natale et al.
[1] also used counts of remaining neurons to measure
neuron death in brain injury but their method of brain
injury allowed counting to be conducted in the same
region in both wild type MT-I/II
-/- mice. In the present
study there were no significant differences between
injury sizes in wild type and MT-I/II
-/- mice and cell
counts were conducted based on a specific marker of
neuronal death.
Crowthers et al. [9] have reported that MT-I/II
-/- mice
have altered numbers of T cells in the blood and spleen
when compared to wild type mice but other investiga-
tors found no difference in T cell numbers in the spleen
and lymph nodes of wild type and MT-I/II
-/- mice [25].
In the present study, leukocyte numbers in MT-I/II
-/-
mice were only found to differ after brain injury. Extra-
cellular MT-I/II has been shown to have modulatory
effects on multiple types of leukocytes [9-14,33,34].
Increases in extracellular MT have been observed in the
blood of head injured patients despite the fact that MT-
I/II protein has no secretory signal sequence [35]. How-
ever, the concentration of MT-I/II required to modulate
the activity of immune cells in vitro is often higher than
the levels of MT observed in circulation before or after
head injury so further study is required to determine
whether this mechanism is possible under the physiolo-
gical conditions that occur after brain injury.
A possible mechanism by which MT-I/II acts on the
immune system that has received little attention is that
the zinc-binding ability of MT-I/II may affect immune
system functioning. Zinc supplementation in humans
has been shown to enhance leukocyte responses to acti-
vating stimuli [36] and zinc homeostasis is known to be
disrupted by brain injury [37]. We have recently demon-
strated that zinc is released from hepatic stores in mice
after brain injury and that MT-I/II
-/- mice have a
reduced capacity for zinc sequestration to the liver, a
process that occurs at 7 DPI in wild type mice (Pan-
khurst et al., manuscript submitted). The co-occurrence
of this event with many of the altered immune system
responses observed at 7 DPI in the present study pro-
vides evidence that MT-I/II mediated zinc homeostasis
may be linked to immune system functioning.
We can not exclude the possibility that MT-I/II is
interacting with more than one process that affects the
injured brain. Increased Ym1 mRNA expression is a
marker for aaMFs [38] and was found to be signifi-
cantly higher in wild type mice than MT-I/II
-/- mice in
both the injury site and PBMCs. The fact that Ym1 was
higher in wild type mice compared to MT-I/II
-/- mice
before injury implies that wild type macrophages have a
greater intrinsic disposition to become aaMFst h a n
those from MT-I/II
-/- mice. This intriguing observation
Figure 6 Scatter plot showing detectable plasma IL-2
concentrations in MT-I/II
-/- mice (crosses) and wild type mice
(circles) after brain injury. Values below the detection limit (0.4
pg/ml) are not shown. Increases in IL-2 in plasma after injury were
sporadic with few animals posting detectable concentrations. At 7
DPI only MT-I/II
-/- mice have detectable levels of plasma IL-2. n = 7
for all groups except wild type mice at zero DPI and MT-I/II
-/- mice
at 7 DPI for which n = 6, error bars = SEM.
Figure 7 (A) Ym1 mRNA expression is greater in the injury site
of wild type mice (solid lines) than in MT-I/II
-/- mice (dashed
lines), n = 6-7, error bars = SEM. (B) Ym1 mRNA expression is
significantly greater in the circulating PBMCs of wild type mice
(Solid lines) than in MT-I/II
-/- mice (dashed lines), independent of
time after injury, n = 6, error bars = SEM.
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sis in the liver of mice lacking MT-I/II. This trend was
retained throughout the period after brain injury and
may be partly responsible for the increased neuron
death that was observed at 7 DPI in MT-I/II
-/- mice
compared to wild type mice. In vitro,t h ea a M F
response has been shown to be much less neurotoxic
than the caMF response which is purported to be due
to the higher production of reactive oxygen species by
caMFs [24]. CaMFs also produce higher levels of neu-
rotoxic metabolites via the quinolinic acid pathway
[39,40]. Th1 cytokines are responsible for the genera-
tion of caMFs and Th2 cytokines are responsible for
the generation of aaMFs. We have previously shown
that exogenous application of MT-I/II to the injured
rat brain leads to a reduction in quinolinic acid pro-
duction and extracellular application of MT-I/II to cul-
tured microglia reduces Th1 cytokine-mediated (IFN-g)
production of quinolinic acid [41]. This is supported
by the finding that naive T cells isolated from MT-I/
II
-/- mice have been shown to be more responsive to
becoming Th1 cells than T cells from wild type mice
[25]. One limitation of the present study is that mea-
surement of the Th1/Th2 responses were not possible
a n dw eh a v eo n l yp r o v i d e das i n g l em a r k e ro fa a M Fs
hence more experiments are required to determine if
differential macrophage activation is occurring in MT-
I/II
-/- mice and whether Th1/Th2 ratios differ. Immu-
noassay and RT-PCR of cytokines were not sensitive
enough to definitively determine the relative ratios of
the Th1 and Th2 responses in the injured brain in the
present study. This was most likely due to the small
tissue sample sizes and the fact that cytokines can
operate at very low concentrations. However, IL-2 was
detectable in the plasma of some animals and it was
interesting to find that at 7 DPI only MT-I/II
-/- mice
were producing detectable amounts of IL-2. IL-2 is
responsible for the clonal expansion of activated T
cells [42] and we regard this as evidence that T cell
activity was altered in MT-I/II
-/- mice after brain
injury and may explain the differences observed in T
cell infiltration in MT-I/II
-/- mice.
Conclusions
MT-I/II expression is increased in the brain after brain
injury which suggests that some of the protective effects
of MT-I/II after brain injury are acting directly on the
injured brain. However, many of the processes observed
in the current study are initiated outside the CNS.
Therefore, it is possible that MT-I/II produced outside
the injured brain could be more important for the mod-
ulation of immune response after brain injury than MT-
I/II produced within the CNS. Such an interaction
would increase the prospects for the use of MT-I/II as a
therapeutic for brain injury.
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